Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials. J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Apr. 19];3:S38. Available from: https://skin.dermsquared.com/skin/article/view/765